# Study Evaluating Patients With Cystinuria

> **NCT04137978** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Advicenne Pharma**

## Conditions studied

- Cystinuria

## Interventions

- **DRUG:** ADV7103
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT04137978
- **Lead sponsor:** Advicenne Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unspecified business decision/strategic reason
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137978, "Study Evaluating Patients With Cystinuria". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04137978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*